Jacobio Pharmaceuticals Group Co., Ltd. (HKG:1167)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.15
+0.60 (9.16%)
At close: Mar 27, 2026

HKG:1167 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-155.71-359.12-371.86-301.19
Depreciation & Amortization
26.4625.0813.810.79
Loss (Gain) From Sale of Assets
0.14-0.63--
Loss (Gain) From Sale of Investments
0.027.24-4.19-0.19
Stock-Based Compensation
9.9614.8616.9919.45
Other Operating Activities
-32.06-38.48-79.0715.25
Change in Accounts Receivable
1.665.6979.0789.03
Change in Accounts Payable
36.77-15.3645.522.77
Change in Unearned Revenue
-0.42-0.42-0.42-3.24
Change in Other Net Operating Assets
39.06-3.077.75-0.16
Operating Cash Flow
-74.12-364.2-292.42-147.49
Capital Expenditures
-12.09-37.83-16.44-10.11
Sale of Property, Plant & Equipment
0.261.730.090.01
Sale (Purchase) of Intangibles
--0.83-0.06-1.03
Investment in Securities
217.47-27.71-667.47178.76
Other Investing Activities
50.5917.25-2.43-5.97
Investing Cash Flow
256.22-47.39-686.32161.67
Long-Term Debt Issued
87.773.62--
Total Debt Issued
87.773.62--
Long-Term Debt Repaid
-100.28-13.5-7.6-11.37
Total Debt Repaid
-100.28-13.5-7.6-11.37
Net Debt Issued (Repaid)
-12.5860.12-7.6-11.37
Issuance of Common Stock
45199.14-132.83
Repurchase of Common Stock
-4.57-5.68--
Other Financing Activities
-6.58-7.91-2.26-12.41
Financing Cash Flow
21.28245.66-9.85109.06
Foreign Exchange Rate Adjustments
4.5510.785.77-26.44
Net Cash Flow
207.94-155.22-902.8396.79
Free Cash Flow
-86.21-402.03-308.86-157.6
Free Cash Flow Margin
-55.37%-632.92%-322.58%-103.13%
Free Cash Flow Per Share
-0.11-0.52-0.41-0.21
Cash Interest Paid
6.587.912.260.51
Levered Free Cash Flow
-41.72-267.43-158.82-67.48
Unlevered Free Cash Flow
-36.47-262.23-157.41-67.12
Change in Working Capital
77.07-13.15131.92108.4
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.